506 related articles for article (PubMed ID: 10493479)
1. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial.
Lillemoe KD; Cameron JL; Hardacre JM; Sohn TA; Sauter PK; Coleman J; Pitt HA; Yeo CJ
Ann Surg; 1999 Sep; 230(3):322-8; discussion 328-30. PubMed ID: 10493479
[TBL] [Abstract][Full Text] [Related]
2. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life.
Van Heek NT; De Castro SM; van Eijck CH; van Geenen RC; Hesselink EJ; Breslau PJ; Tran TC; Kazemier G; Visser MR; Busch OR; Obertop H; Gouma DJ
Ann Surg; 2003 Dec; 238(6):894-902; discussion 902-5. PubMed ID: 14631226
[TBL] [Abstract][Full Text] [Related]
3. Current status of surgical palliation of periampullary carcinoma.
Lillemoe KD; Sauter PK; Pitt HA; Yeo CJ; Cameron JL
Surg Gynecol Obstet; 1993 Jan; 176(1):1-10. PubMed ID: 7678945
[TBL] [Abstract][Full Text] [Related]
4. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s.
Sohn TA; Lillemoe KD; Cameron JL; Huang JJ; Pitt HA; Yeo CJ
J Am Coll Surg; 1999 Jun; 188(6):658-66; discussion 666-9. PubMed ID: 10359359
[TBL] [Abstract][Full Text] [Related]
5. Complications of palliative hepaticojejunostomy and gastrojejunostomy in unresectable periampullary cancer: patient- and disease-related risk factors.
Räty S; Sand J; Piironen A; Nordback I
Hepatogastroenterology; 2006; 53(67):133-7. PubMed ID: 16506392
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of gastric outlet obstruction in unresectable periampullary adenocarcinoma.
Shyr YM; Su CH; Wu CW; Lui WY
World J Surg; 2000 Jan; 24(1):60-4; discussion 64-5. PubMed ID: 10594205
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic gastrojejunostomy for unresectable periampullary carcinoma.
Gurusamy KS; Kumar S; Davidson BR
Cochrane Database Syst Rev; 2010 Oct; (10):CD008533. PubMed ID: 20927775
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic gastrojejunostomy for unresectable periampullary carcinoma.
Gurusamy KS; Kumar S; Davidson BR
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008533. PubMed ID: 23450583
[TBL] [Abstract][Full Text] [Related]
9. Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome.
Sohn TA; Lillemoe KD; Cameron JL; Pitt HA; Huang JJ; Hruban RH; Yeo CJ
Ann Surg; 1999 Mar; 229(3):393-400. PubMed ID: 10077052
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of three types of gastrojejunostomy in unresectable periampullary cancer.
Shyr YM; Su CH; King KL; Wang HC; Lo SS; Wu CW; Lui WY
Surgery; 1997 May; 121(5):506-12. PubMed ID: 9142148
[TBL] [Abstract][Full Text] [Related]
11. Staging laparoscopy in patients scheduled for pancreaticoduodenectomy minimizes hospitalization in the remaining life time when metastatic carcinoma is found.
Beenen E; van Roest MH; Sieders E; Peeters PM; Porte RJ; de Boer MT; de Jong KP
Eur J Surg Oncol; 2014 Aug; 40(8):989-94. PubMed ID: 24582004
[TBL] [Abstract][Full Text] [Related]
12. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
13. Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease.
Mann CD; Thomasset SC; Johnson NA; Garcea G; Neal CP; Dennison AR; Berry DP
ANZ J Surg; 2009 Jun; 79(6):471-5. PubMed ID: 19566872
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of gastrojejunostomy with duodenal partition versus antrectomy in unresectable periampullary cancer.
Shyr YM; Su CH; Wu CW; Lui WY
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Aug; 64(8):443-50. PubMed ID: 11720142
[TBL] [Abstract][Full Text] [Related]
15. Palliative surgical bypass for unresectable periampullary carcinoma.
Singh S; Sachdev AK; Chaudhary A; Agarwal AK
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):308-12. PubMed ID: 18522888
[TBL] [Abstract][Full Text] [Related]
16. Palliative surgery for unresectable pancreatic and periampullary cancer: a reappraisal.
Lesurtel M; Dehni N; Tiret E; Parc R; Paye F
J Gastrointest Surg; 2006 Feb; 10(2):286-91. PubMed ID: 16455463
[TBL] [Abstract][Full Text] [Related]
17. Reoperative surgery for periampullary adenocarcinoma.
McGuire GE; Pitt HA; Lillemoe KD; Niederhuber JE; Yeo CJ; Cameron JL
Arch Surg; 1991 Oct; 126(10):1205-10; discussion 1210-2. PubMed ID: 1681794
[TBL] [Abstract][Full Text] [Related]
18. A wait-and-see strategy with subsequent self-expanding metal stent on demand is superior to prophylactic bypass surgery for unresectable periampullary cancer.
Williamsson C; Wennerblom J; Tingstedt B; Jönsson C
HPB (Oxford); 2016 Jan; 18(1):107-12. PubMed ID: 26776858
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic, prophylactic, and preresection applications of laparoscopic gastric and biliary bypass for patients with periampullary malignancy.
Hamade AM; Al-Bahrani AZ; Owera AM; Hamoodi AA; Abid GH; Bani Hani OI; O'Shea S; Lee SH; Ammori BJ
Surg Endosc; 2005 Oct; 19(10):1333-40. PubMed ID: 16021372
[TBL] [Abstract][Full Text] [Related]
20. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.
Yeo CJ; Cameron JL; Sohn TA; Coleman J; Sauter PK; Hruban RH; Pitt HA; Lillemoe KD
Ann Surg; 1999 May; 229(5):613-22; discussion 622-4. PubMed ID: 10235519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
